| Lipid Composition for FDC-372 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 7.08 | 9 | 90 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 0.81 | 1 | 10 |
| Total | 7.89 mg/ml | 10 mM | 100 |
| Lipid Composition for FDC-373 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 6.29 | 8 | 80 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 1.62 | 2 | 20 |
| Total | 7.91 mg/ml | 10 mM | 100 |
| Lipid Composition for FDC-374 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 5.50 | 7 | 70 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 2.43 | 3 | 30 |
| Total | 7.93 mg/ml | 10 mM | 100 |
| Lipid Composition for FDC-375 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 4.72 | 6 | 60 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 3.24 | 4 | 40 |
| Total | 7.96 mg/ml | 10 mM | 100 |
| Lipid Composition for FDC-376 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 3.93 | 5 | 50 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 4.05 | 5 | 50 |
| Total | 7.98 mg/ml | 10 mM | 100 |
| Lipid Composition for FDC-377 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 3.14 | 4 | 40 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 4.86 | 6 | 60 |
| Total | 8.00 mg/ml | 10 mM | 100 |
| Lipid Composition for FDC-378 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 2.36 | 3 | 30 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 5.67 | 7 | 70 |
| Total | 8.03 mg/ml | 10 mM | 100 |
| Lipid Composition for FDC-379 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 1.57 | 2 | 20 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 6.48 | 8 | 80 |
| Total | 8.05 mg/ml | 10 mM | 100 |
| Lipid Composition for FDC-380 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.79 | 1 | 10 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 7.29 | 9 | 90 |
| Total | 8.08 mg/ml | 10 mM | 100 |
| Lipid Composition for FDC-381 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 8.10 | 10 | 100 |
